A Phase I Trial of IRS-1 HSV C134 Administered Intratumorally in Patients with Recurrent Malignant Glioma

Grant

Date/time Interval

  • September 1, 2019 - August 31, 2022
  • Total Award Amount

  • 798311.00
  • Direct Costs

  • 798311.00
  • Sponsor Award Id

  • G-17-1400
  • Contributor

  • Aban, Inmaculada   Investigator  
  • Cutter, Gary   Investigator  
  • Gillespie, George   Investigator  
  • Leavenworth Ph.D., Jianmei   Investigator  
  • Markert M.D., M.P.H., James   Principal Investigator  
  • Miller, C. Ryan   Investigator  
  • Nabors M.D., Louis   Investigator